Lilly Sues Teva To Block Generic Symbyax
Eli Lilly and Co. has filed a lawsuit to bar Israeli drug maker Teva Pharmaceutical Industries Ltd. from marketing a generic version of the anti-psychotic drug Symbyax....To view the full article, register now.
Already a subscriber? Click here to view full article